{
    "title": "Epirus, Ranbaxy win India approval for arthritis drug copy",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-2756975/Epirus-Ranbaxy-win-India-approval-arthritis-drug-copy.html",
    "date": "2014-09-15",
    "keywords": [
        "drug",
        "market",
        "ranbaxy",
        "india",
        "approval",
        "version",
        "remicade",
        "copy",
        "gmt",
        "september",
        "arthritis",
        "incs",
        "biotech",
        "year",
        "name",
        "infimab",
        "reliance",
        "drugmaker",
        "ltd",
        "epirus",
        "email",
        "grover",
        "zeba",
        "regulator",
        "treatment",
        "way",
        "launch",
        "country",
        "yearthe",
        "companys",
        "partner",
        "johnson",
        "infliximab",
        "billionthe",
        "copycat",
        "antibody",
        "rank",
        "industrys",
        "sellerswith",
        "patent",
        "cliff",
        "research",
        "firm",
        "httpbitly1or6jqfinfliximab",
        "brand",
        "crohns",
        "disease",
        "psoriasis",
        "monthlike",
        "enbrel",
        "protein",
        "tumor",
        "necrosis",
        "company",
        "sale",
        "biosimilar",
        "quarter",
        "executive",
        "amit",
        "mumbai",
        "life",
        "part",
        "billionaire",
        "anil",
        "ambanis",
        "group",
        "celltrion",
        "inc",
        "july",
        "japan",
        "reutersranbaxy",
        "license",
        "asia",
        "north",
        "africa",
        "americaranbaxy",
        "production",
        "reddys",
        "example",
        "kgaabiocon",
        "tieup",
        "mylan",
        "lupin",
        "deal",
        "sas",
        "blockbuster",
        "insulin",
        "lantus",
        "editing",
        "robin",
        "paxton"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}